Results 131 to 140 of about 5,072 (192)

Levodopa Efficacy and GLP‐1 Receptor Agonists

open access: yes
Movement Disorders Clinical Practice, Volume 13, Issue 8, Page 2013-2014, August 2026.
Catherine Martinez   +3 more
wiley   +1 more source

International Guideline on the Diagnosis and Management of Pediatric Patients With Hereditary Angioedema

open access: yesAllergy, Volume 81, Issue 8, Page 2744-2774, August 2026.
ABSTRACT Hereditary angioedema (HAE) with C1 inhibitor deficiency is a rare disease characterized by unpredictable episodes of tissue swelling (angioedema), which, in most cases, occur first under the age of 18 years, and entail a significant burden of disease not only for the patients but also for their families.
Henriette Farkas   +128 more
wiley   +1 more source

Miraklernes tid

open access: yes, 2007
Artiklen diskuterer Kaj Munks syn på miraklet, idet der især tages hensyn til behandlingen af dette tema i "Ordet". Herunder diskuteres bl.a. Munks overvejelser om naturen og naturlovene set i relation til kristen virkelighedsforståelse.
openaire   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Tid og kræft

Tidsskrift for forskning i sygdom og samfund, 2014
En introduktion til Tidsskrift for Forskning i Sygdom og Samfund nr. 20: Tid og Kræft.
Sand Andersen, Rikke   +1 more
openaire   +1 more source

Shackle i tid - tid i Shackle

2015
GLS Shackle got much and the crucial inspiration from John Maynard Keynes. But that's not all. He took a number of further consequences of Keynes’ thoughts. This implies for example ideal claims to economists - having to deal with both mechanical time and expectational time.
openaire   +1 more source

Combined Effect of TID Radiation and Electrical Stress on NMOSFETs

Micromachines, 2022
Enxia Zhang, Ma Xiaohua, Wang Yongkun
exaly  

Modified TID controller for load frequency control of a two-area interconnected diverse-unit power system

International Journal of Electrical Power and Energy Systems, 2022
Gaber Magdy   +2 more
exaly  

Home - About - Disclaimer - Privacy